Pembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With Residual Disease After Neoadjuvant Pembrolizumab Plus Chemotherapy

Name: Pembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With Residual Disease After Neoadjuvant Pembrolizumab Plus Chemotherapy
License: Public Domain

The Netherlands Cancer Institute

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

triple

triple negative breast cancer (tnbc), early setting, early stage triple-negative breast carcinoma, triple -negative breast cancer, breast cancer stage ii, breast cancer stage iii

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 234433
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.